M42’s IROS launches UAE’s first genomics-driven clinical trial to prevent Alzheimer’s disease
Alzheimer’s disease is one of the world’s most pressing health challenges, affecting more than 55 million people globally; a number expected to nearly triple by 2050.
Posted in BioUtah News
Tagged halia therapeutics, M42
Comments Off on M42’s IROS launches UAE’s first genomics-driven clinical trial to prevent Alzheimer’s disease
